The Oxford-Harrington Rare Disease Centre ('OHC') today announced the recipients of the 2025 Rare Disease Scholar Award, which ...

The FDA has issued a CRL to Biohaven regarding the NDA for troriluzole for the treatment of adults with spinocerebellar ataxia.

Biohaven (BHVN) downgraded after FDA setback for VYGLXIA. Learn key risks, pipeline shifts, and what investors should watch next. Click here to read more.

Biohaven is proposing troriluzole for the treatment of spinocerebellar ataxia, a group of rare, genetic diseases that lead to the progressive loss of control over movement.

A green light would have made Vyglxia the first and only FDA-approved treatment for spinocerebellar ataxia, a life-threatening neurodegenerative disease characterized by progressive loss of voluntary ...

The American Academy of Sleep Medicine (AASM) has updated its guidelines for the treatment of restless legs syndrome (RLS) for the first time in 12 years. In this video interview, guideline author ...

Robbie Williams, a former member of the '90s boy band Take That who's gone on to a successful solo career, says he struggles with Tourette syndrome. "I've just realized that I have Tourette's, but ...

Correspondence to Dr Thiago Junqueira Ribeiro Rezende, Department of Neurology, University of Campinas (UNICAMP), Campinas, SP, Brazil; thiago.jrezende{at}gmail.com Background Spinal cord damage is a ...

This Saturday morning, downtown Oklahoma City will be filled with runners, walkers, and some really cool families, all coming together for a really good cause. “This is the Down Syndrome Festival and ...

Never heard of kissing bugs? Well, a recent report from the Centers For Disease Control and Prevention is sounding the alarm about the rising prevalence of the biting insects in the United States and ...